Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PAT-SM6 |
Trade Name | |
Synonyms | |
Drug Descriptions |
PAT-SM6 is a monoclonal antibody directed against GRP78, which may result in increased apoptosis and decreased growth of GRP78-expressing tumor cells, especially in combination with other agents (PMID: 23667612, PMID: 27029491, PMID: 31766302). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C103857 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bortezomib + Lenalidomide + PAT-SM6 | Bortezomib Lenalidomide PAT-SM6 | 0 | 0 |
Dexamethasone + Lenalidomide + PAT-SM6 | Dexamethasone Lenalidomide PAT-SM6 | 0 | 0 |
Dexamethasone + PAT-SM6 | Dexamethasone PAT-SM6 | 0 | 0 |
Lenalidomide + PAT-SM6 | Lenalidomide PAT-SM6 | 0 | 0 |
PAT-SM6 | PAT-SM6 | 0 | 0 |